FOXA2 |
A549 (lung carcinoma) |
1 h with 0.02% Ethanol (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000BRE
|
MA0047.3
|
FOXA2 |
neuralized embryoid body |
all trans retinoic acid (RA) and SAG for 3 days before harvested |
Permissive
Robust
|
Mus musculus |
GSE42132
...
|
MA0047.3
|
FOXA2 |
pancreatic beta-cells |
none |
Permissive
Robust
|
Mus musculus |
GSE54046
...
|
MA0047.3
|
FOXA2 |
DLK1+ hepatoblasts |
none |
Permissive
Robust
|
Mus musculus |
GSE54520
...
|
MA0047.3
|
FOXA2 |
CyT49-derived endodermal cells |
none |
Permissive
|
Homo sapiens |
GSE54471
...
|
MA0047.3
|
FOXA2 |
CyT49-derived endodermal cells |
none |
Permissive
|
Homo sapiens |
GSE54471
...
|
MA0047.3
|
FOXA2 |
CyT49-derived endodermal cells |
none |
Permissive
|
Homo sapiens |
GSE54471
...
|
MA0047.3
|
FOXA2 |
liver |
E2 |
Permissive
Robust
|
Mus musculus |
GSE70346
...
|
MA0047.3
|
FOXA2 |
liver |
E2, ER KO |
Permissive
Robust
|
Mus musculus |
GSE70346
...
|
MA0047.3
|
FOXA2 |
endometrioid adenocarcinoma |
tumor A |
Permissive
Robust
|
Homo sapiens |
GSE81213
...
|
MA0047.3
|
FOXA2 |
endometrioid adenocarcinoma |
tumor C |
Permissive
Robust
|
Homo sapiens |
GSE81213
...
|
MA0047.3
|
FOXA2 |
endometrioid adenocarcinoma |
tumor E |
Permissive
Robust
|
Homo sapiens |
GSE81213
...
|
MA0047.3
|
FOXA2 |
endometrioid adenocarcinoma |
tumor B |
Permissive
|
Homo sapiens |
GSE81213
...
|
MA0047.3
|
FOXA2 |
endometrium |
Phase: P (proliferative) |
Permissive
|
Homo sapiens |
GSE121586
...
|
MA0047.3
|
FOXA2 |
endometrium |
Phase: MS (mid-secretory) |
Permissive
|
Homo sapiens |
GSE121586
...
|
MA0047.3
|
FOXA2 |
HepG2 (hepatoblastoma) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL |
Permissive
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
HepG2 (hepatoblastoma) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL |
Permissive
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
KerCT (keratenocytes) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL |
Permissive
Robust
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
KerCT (keratenocytes) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL |
Permissive
Robust
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
KerCT (keratenocytes) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL |
Permissive
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
definitive endoderm(dEN, ES derived) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL |
Permissive
Robust
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
definitive endoderm(dEN, ES derived) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL |
Permissive
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
BJ (fibroblasts) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: cTermCDT1 |
Permissive
Robust
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
BJ (fibroblasts) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: wildtype FOCA2 |
Permissive
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
BJ (fibroblasts) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: CDT1 mimo FOXA2 |
Permissive
Robust
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
BJ (fibroblasts) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: FOXA2 mimo |
Permissive
Robust
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
BJ (fibroblasts) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: FOXA2 mimo release |
Permissive
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
BJ (fibroblasts) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: FOXA2 unind |
Permissive
Robust
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
BJ (fibroblasts) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL |
Permissive
Robust
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
A549 (lung carcinoma) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL |
Permissive
Robust
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
BJ (fibroblasts) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: Mimo FOXA2 |
Permissive
Robust
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
BJ (fibroblasts) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: FOXA2 mimo released |
Permissive
Robust
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
BJ (fibroblasts) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: FOXA2 {delta}C |
Permissive
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
BJ (fibroblasts) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: FOXA2 {delta}N |
Permissive
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
BJ (fibroblasts) |
Treatment: addition of 200 uM mimosine over night Genotype: Clonal FOXA2 doxycycline inducible cells |
Permissive
Robust
|
Homo sapiens |
GSE92491
...
|
MA0047.3
|
FOXA2 |
BJ (fibroblasts) |
Treatment: addition of 200 uM mimosine over night Genotype: Clonal FOXA2 doxycycline inducible cells |
Permissive
Robust
|
Homo sapiens |
GSE92491
...
|
MA0047.3
|
FOXA2 |
BJ (fibroblasts) |
Genotype: clonal FOXA2 doxycycline inducible cells, OXA2 GATA4 Coexpressing |
Permissive
Robust
|
Homo sapiens |
GSE92491
...
|
MA0047.3
|
FOXA2 |
BJ (fibroblasts) |
Genotype: Clonal FOXA2 doxycycline inducible cells, CDT1 |
Permissive
Robust
|
Homo sapiens |
GSE92491
...
|
MA0047.3
|
FOXA2 |
liver |
CARN1618 |
Permissive
Robust
|
Homo sapiens |
ERP008682
|
MA0047.3
|
FOXA2 |
pancreas |
CARN1618 |
Permissive
Robust
|
Homo sapiens |
ERP008682
|
MA0047.3
|
FOXA2 |
HepG2 (hepatoblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BNI
|
MA0047.3
|
FOXA2 |
liver |
|
Permissive
Robust
|
Homo sapiens |
ENCSR080XEY
|
MA0047.3
|
FOXA2 |
liver |
|
Permissive
Robust
|
Homo sapiens |
ENCSR310NYI
|
MA0047.3
|
FOXA2 |
HepG2 (hepatoblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR066EBK
|
MA0047.3
|
FOXA2 |
liver |
|
Permissive
Robust
|
Mus musculus |
GSE26729
...
|
MA0047.3
|
FOXA2 |
liver |
|
Permissive
Robust
|
Homo sapiens |
GSE25836
...
|
MA0047.3
|
FOXA2 |
liver |
|
Permissive
Robust
|
Mus musculus |
GSE25836
...
|
MA0047.3
|
FOXA2 |
embryonic stem cell-derived endodermal cells |
|
Permissive
Robust
|
Mus musculus |
GSE40423
...
|
MA0047.3
|
FOXA2 |
pancreas |
|
Permissive
|
Mus musculus |
GSE47459
...
|
MA0047.3
|
FOXA2 |
uterus |
|
Permissive
|
Mus musculus |
GSE48238
...
|
MA0047.3
|
FOXA2 |
uterus |
|
Permissive
Robust
|
Mus musculus |
GSE48238
...
|
MA0047.3
|
FOXA2 |
hepatocytes |
|
Permissive
Robust
|
Mus musculus |
GSE17067
...
|
MA0047.3
|
FOXA2 |
HUES64-derived endodermal cells |
|
Permissive
|
Homo sapiens |
GSE46130
...
|
MA0047.3
|
FOXA2 |
liver |
|
Permissive
Robust
|
Mus musculus |
GSE57556
...
|
MA0047.3
|
FOXA2 |
liver |
|
Permissive
Robust
|
Mus musculus |
GSE60393
...
|
MA0047.3
|
FOXA2 |
liver |
|
Permissive
Robust
|
Mus musculus |
GSE60393
...
|
MA0047.3
|
FOXA2 |
HUES64 (embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE61475
...
|
MA0047.3
|
FOXA2 |
HUES64 (embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE61475
...
|
MA0047.3
|
FOXA2 |
HUES64 (embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE61475
...
|
MA0047.3
|
FOXA2 |
|
|
Permissive
Robust
|
Homo sapiens |
ERP003828
|
MA0047.3
|
FOXA2 |
pancreatic islets |
|
Permissive
Robust
|
Homo sapiens |
ERP004003
|
MA0047.3
|
FOXA2 |
H9 |
|
Permissive
Robust
|
Homo sapiens |
ERP004206
|
MA0047.3
|
FOXA2 |
Caco-2 (colon adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE66218
|
MA0047.3
|